Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Self-Adhering Magnetic Device to Treat Corneal Exposure

NCT: NCT06291818 · RECRUITING

NCT IDNCT06291818
StatusRECRUITING
Start Date2024-04-17
Completion2027-09-01

Brief Summary

Paralytic lagophthalmos can be difficult to treat and manage. It has a host of causes and effects, one of which (for the latter) is exposure keratopathy. Untreated, this can lead to corneal ulceration, inflammation, and potentially blindness. Despite a variety of attempts at treating this complex condition, none have satisfactorily reduced complications ranging from ease of use to aesthetics. With improvement in magnetic technology, however, that may change. Barmettler et al (2014) have demonstrated preliminary success of externally affixed magnets in closing both model and patient eyelids. As such, we hypothesize that magnetic devices can be used to treat corneal exposure by controlling eyelid position.

Frequently Asked Questions

What is Self-Adhering Magnetic Device to Treat Corneal Exposure?

Self-Adhering Magnetic Device to Treat Corneal Exposure is a clinical trial registered under NCT06291818. Current status: RECRUITING.

What is the status of NCT06291818?

The current status of NCT06291818 (Self-Adhering Magnetic Device to Treat Corneal Exposure) is: RECRUITING.

When did Self-Adhering Magnetic Device to Treat Corneal Exposure start?

Self-Adhering Magnetic Device to Treat Corneal Exposure started on 2024-04-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.